BSE filing, NSE: CONFINT. Summary written from the filing by ALFA Finder's alert engine.
Longspur International Ventures Ltd: key numbers
- Share price
- ₹7.39
- Market cap
- ₹10.09 Cr
- Revenue (annual)
- ₹4.13 Cr
- Net profit (annual)
- ₹0.53 Cr
- P/E (TTM)
- 20.3×Sector 19.7×
- Promoter holding
- 16.74%-6.65% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Longspur International Ventures Ltd
All →Longspur International Ventures Board Meeting Date
Longspur International Ventures will hold a board meeting on November 5, 2026 to consider unaudited standalone half-year results for the period ended September 2026. The trading window is closed from October 1 to November 7, 2026.
Longspur International Ventures Preferential Issue
Longspur International Ventures Ltd received BSE listing approval for 1,72,50,000 equity shares allotted on a preferential basis to promoters and non-promoters.
Longspur International Ventures Annual General Meeting
Longspur International Ventures Limited held its 46th Annual General Meeting on September 30, 2026. Key agenda items included the adoption of FY26 financial statements and director re-appointments.
Longspur International Ventures Annual General Meeting
Longspur International Ventures approved the Notice of its 46th Annual General Meeting and the related book closure dates in a board meeting on September 8, 2026.
Longspur International Ventures Other Announcement
Longspur International Ventures Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, as per regulatory requirements.
Longspur International Ventures Other Announcement
Longspur International Ventures announced a change in its Corporate Identification Number (CIN) to L64990MH1980PLC231713. This follows an alteration to the company's Main Object Clause.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.